Clinical Trial Update: Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing CM512 was studied in healthy subjects and patients with Atopic Dermatitis, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM512

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED